Global Biochemical Befense Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 277303
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Technology
Buy @ $3500

The Biochemical Befense market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Biochemical Befense market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

Global key companies of Biochemical Befense include Emergent Biosolutions, Hytest, GSK, Sanofi, and PharmAthene, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Biochemical Befense market is split by Type and by Application. For the period 2012-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Anthrax

Smallpox

Botulism

Radiation/Nuclear

Other

Market segment by Application, can be divided into

National Defense

Military

Market segment by players, this report covers

Emergent Biosolutions

Hytest

GSK

Sanofi

PharmAthene

Bavarian Nordic

SIGA Technologies

Arbutus Biopharma

DynPort Vaccine

Xoma Corporation

Ichor Medical Systems

Aeolus Pharmaceuticals

Achaogen

Elusys Therapeutics

Dynavax Technologies

Cleveland BioLabs

Soligenix

Alnylam Pharmaceuticals

Market segment by regions, regional analysis covers

North America

Europe

Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)

South America

Middle East & Africa

The content of the study subjects, includes a total of 8 chapters:

Chapter 1, to describe Biochemical Befense product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Biochemical Befense, with recent developments and future plans

Chapter 3, the Biochemical Befense competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4, to break the market size data at the region level, with key companies in the key region and Biochemical Befense market forecast, by regions, with revenue, from 2022 to 2028.

Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2022 to 2028.

Chapter 7 and 8, to describe Biochemical Befense research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1 Market Overview

1.1 Product Overview and Scope of Biochemical Befense

1.2 Classification of Biochemical Befense by Type

1.2.1 Overview: Global Biochemical Befense Market Size by Type: 2022 Versus 2028

1.2.2 Global Biochemical Befense Revenue Market Share by Type in 2028

1.2.3 Anthrax

1.2.4 Smallpox

1.2.5 Botulism

1.2.6 Radiation/Nuclear

1.2.7 Other

1.3 Global Biochemical Befense Market by Application

1.3.1 Overview: Global Biochemical Befense Market Size by Application: 2022 Versus 2028

1.3.2 National Defense

1.3.3 Military

1.4 Global Biochemical Befense Market Size & Forecast

1.5 Market Drivers, Restraints and Trends

1.5.1 Biochemical Befense Market Drivers

1.5.2 Biochemical Befense Market Restraints

1.5.3 Biochemical Befense Trends Analysis

2 Company Profiles

2 Company Profiles

2.1 Emergent Biosolutions

2.1.1 Emergent Biosolutions Details

2.1.2 Emergent Biosolutions Major Business

2.1.3 Emergent Biosolutions Biochemical Befense Product and Solutions

2.1.4 Emergent Biosolutions Recent Developments and Future Plans

2.2 Hytest

2.2.1 Hytest Details

2.2.2 Hytest Major Business

2.2.3 Hytest Biochemical Befense Product and Solutions

2.2.4 Hytest Recent Developments and Future Plans

2.3 GSK

2.3.1 GSK Details

2.3.2 GSK Major Business

2.3.3 GSK Biochemical Befense Product and Solutions

2.3.4 GSK Recent Developments and Future Plans

2.4 Sanofi

2.4.1 Sanofi Details

2.4.2 Sanofi Major Business

2.4.3 Sanofi Biochemical Befense Product and Solutions

2.4.4 Sanofi Recent Developments and Future Plans

2.5 PharmAthene

2.5.1 PharmAthene Details

2.5.2 PharmAthene Major Business

2.5.3 PharmAthene Biochemical Befense Product and Solutions

2.5.4 PharmAthene Recent Developments and Future Plans

2.6 Bavarian Nordic

2.6.1 Bavarian Nordic Details

2.6.2 Bavarian Nordic Major Business

2.6.3 Bavarian Nordic Biochemical Befense Product and Solutions

2.6.4 Bavarian Nordic Recent Developments and Future Plans

2.7 SIGA Technologies

2.7.1 SIGA Technologies Details

2.7.2 SIGA Technologies Major Business

2.7.3 SIGA Technologies Biochemical Befense Product and Solutions

2.7.4 SIGA Technologies Recent Developments and Future Plans

2.8 Arbutus Biopharma

2.8.1 Arbutus Biopharma Details

2.8.2 Arbutus Biopharma Major Business

2.8.3 Arbutus Biopharma Biochemical Befense Product and Solutions

2.8.4 Arbutus Biopharma Recent Developments and Future Plans

2.9 DynPort Vaccine

2.9.1 DynPort Vaccine Details

2.9.2 DynPort Vaccine Major Business

2.9.3 DynPort Vaccine Biochemical Befense Product and Solutions

2.9.4 DynPort Vaccine Recent Developments and Future Plans

2.10 Xoma Corporation

2.10.1 Xoma Corporation Details

2.10.2 Xoma Corporation Major Business

2.10.3 Xoma Corporation Biochemical Befense Product and Solutions

2.10.4 Xoma Corporation Recent Developments and Future Plans

2.11 Ichor Medical Systems

2.11.1 Ichor Medical Systems Details

2.11.2 Ichor Medical Systems Major Business

2.11.3 Ichor Medical Systems Biochemical Befense Product and Solutions

2.11.4 Ichor Medical Systems Recent Developments and Future Plans

2.12 Aeolus Pharmaceuticals

2.12.1 Aeolus Pharmaceuticals Details

2.12.2 Aeolus Pharmaceuticals Major Business

2.12.3 Aeolus Pharmaceuticals Biochemical Befense Product and Solutions

2.12.4 Aeolus Pharmaceuticals Recent Developments and Future Plans

2.13 Achaogen

2.13.1 Achaogen Details

2.13.2 Achaogen Major Business

2.13.3 Achaogen Biochemical Befense Product and Solutions

2.13.4 Achaogen Recent Developments and Future Plans

2.14 Elusys Therapeutics

2.14.1 Elusys Therapeutics Details

2.14.2 Elusys Therapeutics Major Business

2.14.3 Elusys Therapeutics Biochemical Befense Product and Solutions

2.14.4 Elusys Therapeutics Recent Developments and Future Plans

2.15 Dynavax Technologies

2.15.1 Dynavax Technologies Details

2.15.2 Dynavax Technologies Major Business

2.15.3 Dynavax Technologies Biochemical Befense Product and Solutions

2.15.4 Dynavax Technologies Recent Developments and Future Plans

2.16 Cleveland BioLabs

2.16.1 Cleveland BioLabs Details

2.16.2 Cleveland BioLabs Major Business

2.16.3 Cleveland BioLabs Biochemical Befense Product and Solutions

2.16.4 Cleveland BioLabs Recent Developments and Future Plans

2.17 Soligenix

2.17.1 Soligenix Details

2.17.2 Soligenix Major Business

2.17.3 Soligenix Biochemical Befense Product and Solutions

2.17.4 Soligenix Recent Developments and Future Plans

2.18 Alnylam Pharmaceuticals

2.18.1 Alnylam Pharmaceuticals Details

2.18.2 Alnylam Pharmaceuticals Major Business

2.18.3 Alnylam Pharmaceuticals Biochemical Befense Product and Solutions

2.18.4 Alnylam Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

3 Market Competition, by Players

3.1 Global Biochemical Befense Revenue and Share by Players (2022 & 2028)

3.2 Biochemical Befense Players Head Office, Products and Services Provided

3.3 Biochemical Befense Mergers & Acquisitions

3.4 Biochemical Befense New Entrants and Expansion Plans

4 Global Biochemical Befense Forecast by Region

4 Global Biochemical Befense Forecast by Region

4.1 Global Biochemical Befense Market Size by Region: 2022 VS 2028

4.2 Global Biochemical Befense Market Size by Region, (2022-2028)

4.3 North America

4.3.1 Key Companies of Biochemical Befense in North America

4.3.2 Current Situation and Forecast of Biochemical Befense in North America

4.3.3 North America Biochemical Befense Market Size and Prospect (2022-2028)

4.4 Europe

4.4.1 Key Companies of Biochemical Befense in Europe

4.4.2 Current Situation and Forecast of Biochemical Befense in Europe

4.4.3 Europe Biochemical Befense Market Size and Prospect (2022-2028)

4.5 Asia-Pacific

4.5.1 Key Companies of Biochemical Befense in Asia-Pacific

4.5.2 Current Situation and Forecast of Biochemical Befense in Asia-Pacific

4.5.3 Asia-Pacific Biochemical Befense Market Size and Prospect (2022-2028)

4.6 South America

4.6.1 Key Companies of Biochemical Befense in South America

4.6.2 Current Situation and Forecast of Biochemical Befense in South America

4.6.3 South America Biochemical Befense Market Size and Prospect (2022-2028)

4.7 Middle East & Africa

4.7.1 Key Companies of Biochemical Befense in Middle East & Africa

4.7.2 Current Situation and Forecast of Biochemical Befense in Middle East & Africa

4.7.3 Middle East & Africa Biochemical Befense Market Size and Prospect (2022-2028)

5 Market Size Segment by Type

5 Market Size Segment by Type

5.1 Global Biochemical Befense Market Forecast by Type (2022-2028)

5.2 Global Biochemical Befense Market Share Forecast by Type (2022-2028)

6 Market Size Segment by Application

6 Market Size Segment by Application

6.1 Global Biochemical Befense Market Forecast by Application (2022-2028)

6.2 Global Biochemical Befense Market Share Forecast by Application (2022-2028)

7 Research Findings and Conclusion

7 Research Findings and Conclusion

8 Appendix

8 Appendix

8.1 Methodology

8.2 Research Process and Data Source

8.3 Disclaimer

List of Tables

Table 1. Global Biochemical Befense Revenue by Type, (USD Million), 2022 VS 2028

Table 2. Global Biochemical Befense Revenue by Application, (USD Million), 2022 VS 2028

Table 3. Emergent Biosolutions Corporate Information, Head Office, and Major Competitors

Table 4. Emergent Biosolutions Major Business

Table 5. Emergent Biosolutions Biochemical Befense Product and Solutions

Table 6. Hytest Corporate Information, Head Office, and Major Competitors

Table 7. Hytest Major Business

Table 8. Hytest Biochemical Befense Product and Solutions

Table 9. GSK Corporate Information, Head Office, and Major Competitors

Table 10. GSK Major Business

Table 11. GSK Biochemical Befense Product and Solutions

Table 12. Sanofi Corporate Information, Head Office, and Major Competitors

Table 13. Sanofi Major Business

Table 14. Sanofi Biochemical Befense Product and Solutions

Table 15. PharmAthene Corporate Information, Head Office, and Major Competitors

Table 16. PharmAthene Major Business

Table 17. PharmAthene Biochemical Befense Product and Solutions

Table 18. Bavarian Nordic Corporate Information, Head Office, and Major Competitors

Table 19. Bavarian Nordic Major Business

Table 20. Bavarian Nordic Biochemical Befense Product and Solutions

Table 21. SIGA Technologies Corporate Information, Head Office, and Major Competitors

Table 22. SIGA Technologies Major Business

Table 23. SIGA Technologies Biochemical Befense Product and Solutions

Table 24. Arbutus Biopharma Corporate Information, Head Office, and Major Competitors

Table 25. Arbutus Biopharma Major Business

Table 26. Arbutus Biopharma Biochemical Befense Product and Solutions

Table 27. DynPort Vaccine Corporate Information, Head Office, and Major Competitors

Table 28. DynPort Vaccine Major Business

Table 29. DynPort Vaccine Biochemical Befense Product and Solutions

Table 30. Xoma Corporation Corporate Information, Head Office, and Major Competitors

Table 31. Xoma Corporation Major Business

Table 32. Xoma Corporation Biochemical Befense Product and Solutions

Table 33. Ichor Medical Systems Corporate Information, Head Office, and Major Competitors

Table 34. Ichor Medical Systems Major Business

Table 35. Ichor Medical Systems Biochemical Befense Product and Solutions

Table 36. Aeolus Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 37. Aeolus Pharmaceuticals Major Business

Table 38. Aeolus Pharmaceuticals Biochemical Befense Product and Solutions

Table 39. Achaogen Corporate Information, Head Office, and Major Competitors

Table 40. Achaogen Major Business

Table 41. Achaogen Biochemical Befense Product and Solutions

Table 42. Elusys Therapeutics Corporate Information, Head Office, and Major Competitors

Table 43. Elusys Therapeutics Major Business

Table 44. Elusys Therapeutics Biochemical Befense Product and Solutions

Table 45. Dynavax Technologies Corporate Information, Head Office, and Major Competitors

Table 46. Dynavax Technologies Major Business

Table 47. Dynavax Technologies Biochemical Befense Product and Solutions

Table 48. Cleveland BioLabs Corporate Information, Head Office, and Major Competitors

Table 49. Cleveland BioLabs Major Business

Table 50. Cleveland BioLabs Biochemical Befense Product and Solutions

Table 51. Soligenix Corporate Information, Head Office, and Major Competitors

Table 52. Soligenix Major Business

Table 53. Soligenix Biochemical Befense Product and Solutions

Table 54. Alnylam Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 55. Alnylam Pharmaceuticals Major Business

Table 56. Alnylam Pharmaceuticals Biochemical Befense Product and Solutions

Table 57. Global Biochemical Befense Revenue (USD Million) by Players (2022 & 2028)

Table 58. Global Biochemical Befense Revenue Share by Players (2022 & 2028)

Table 59. Biochemical Befense Players Head Office, Products and Services Provided

Table 60. Biochemical Befense Mergers & Acquisitions in the Past Five Years

Table 61. Biochemical Befense New Entrants and Expansion Plans

Table 62. Global Market Biochemical Befense Revenue (USD Million) Comparison by Region (2022 VS 2028)

Table 63. Global Biochemical Befense Revenue Market Share by Region (2022-2028)

Table 64. Key Companies of Biochemical Befense in North America

Table 65. Current Situation and Forecast of Biochemical Befense in North America

Table 66. Key Companies of Biochemical Befense in Europe

Table 67. Current Situation and Forecast of Biochemical Befense in Europe

Table 68. Key Companies of Biochemical Befense in Asia-Pacific

Table 69. Current Situation and Forecast of Biochemical Befense in Asia-Pacific

Table 70. Key Companies of Biochemical Befense in China

Table 71. Key Companies of Biochemical Befense in Japan

Table 72. Key Companies of Biochemical Befense in South Korea

Table 73. Key Companies of Biochemical Befense in South America

Table 74. Current Situation and Forecast of Biochemical Befense in South America

Table 75. Key Companies of Biochemical Befense in Middle East & Africa

Table 76. Current Situation and Forecast of Biochemical Befense in Middle East & Africa

Table 77. Global Biochemical Befense Revenue Forecast by Type (2022-2028)

Table 78. Global Biochemical Befense Revenue Forecast by Application (2022-2028)

List of Figures

Figure 1. Biochemical Befense Picture

Figure 2. Global Biochemical Befense Revenue Market Share by Type in 2028

Figure 3. Anthrax

Figure 4. Smallpox

Figure 5. Botulism

Figure 6. Radiation/Nuclear

Figure 7. Other

Figure 8. Biochemical Befense Revenue Market Share by Application in 2028

Figure 9. National Defense Picture

Figure 10. Military Picture

Figure 11. Global Biochemical Befense Market Size, (USD Million): 2022 VS 2028

Figure 12. Global Biochemical Befense Revenue and Forecast (2022-2028) & (USD Million)

Figure 13. Biochemical Befense Market Drivers

Figure 14. Biochemical Befense Market Restraints

Figure 15. Biochemical Befense Market Trends

Figure 16. Emergent Biosolutions Recent Developments and Future Plans

Figure 17. Hytest Recent Developments and Future Plans

Figure 18. GSK Recent Developments and Future Plans

Figure 19. Sanofi Recent Developments and Future Plans

Figure 20. PharmAthene Recent Developments and Future Plans

Figure 21. Bavarian Nordic Recent Developments and Future Plans

Figure 22. SIGA Technologies Recent Developments and Future Plans

Figure 23. Arbutus Biopharma Recent Developments and Future Plans

Figure 24. DynPort Vaccine Recent Developments and Future Plans

Figure 25. Xoma Corporation Recent Developments and Future Plans

Figure 26. Ichor Medical Systems Recent Developments and Future Plans

Figure 27. Aeolus Pharmaceuticals Recent Developments and Future Plans

Figure 28. Achaogen Recent Developments and Future Plans

Figure 29. Elusys Therapeutics Recent Developments and Future Plans

Figure 30. Dynavax Technologies Recent Developments and Future Plans

Figure 31. Cleveland BioLabs Recent Developments and Future Plans

Figure 32. Soligenix Recent Developments and Future Plans

Figure 33. Alnylam Pharmaceuticals Recent Developments and Future Plans

Figure 34. Global Biochemical Befense Revenue Market Share by Region (2022-2028)

Figure 35. Global Biochemical Befense Revenue Market Share by Region in 2028

Figure 36. North America Biochemical Befense Revenue (USD Million) and Growth Rate (2022-2028)

Figure 37. Europe Biochemical Befense Revenue (USD Million) and Growth Rate (2022-2028)

Figure 38. Asia-Pacific Biochemical Befense Revenue (USD Million) and Growth Rate (2022-2028)

Figure 39. South America Biochemical Befense Revenue (USD Million) and Growth Rate (2022-2028)

Figure 40. Middle East & Africa Biochemical Befense Revenue (USD Million) and Growth Rate (2022-2028)

Figure 41. Global Biochemical Befense Market Share Forecast by Type (2022-2028)

Figure 42. Global Biochemical Befense Market Share Forecast by Application (2022-2028)

Figure 43. Methodology

Figure 44. Research Process and Data Source